Vaccination with mycobacteria and allergies;La vaccination à base de mycobactéries vaincra-t-elle les allergies?

Revue Medicale de Liege

Volumn 58, Issue 6, 2003, Pages 392-395

  Louis, R ^a,b  

^a Service de Pneumologie Hia Laveran   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Allergy; Asthma; BCG; Mycobacterium vaccae; TH1 cells; TH2 cells

Indexed keywords

ALLERGEN; BCG VACCINE;

ALLERGY; ASTHMA; ATOPIC DERMATITIS; BCG VACCINATION; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CELLULAR IMMUNITY; DEVELOPED COUNTRY; DRUG EFFECT; HUMAN; IMMUNE RESPONSE; MYCOBACTERIUM; MYCOBACTERIUM VACCAE; NONHUMAN; PREVALENCE; REVIEW; SENSITIZATION; SKIN MANIFESTATION; TH1 CELL; TH2 CELL; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; ALLERGENS; ASTHMA; BCG VACCINE; CHILD; DERMATITIS, ATOPIC; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; MYCOBACTERIUM; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, PULMONARY;

EID: 0042155470     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Crane J, Wickens K, Beasley R, Fitzharris P. - Asthma and allergy: a worldwide problem of meanings and management? Allergy, 2002, 57, 663-672.
2. Styblo K. - Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis, 1989, 11 Suppl 2, S339-S346.
3. Mosmann TR, Coffman RL. - TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol, 1989, 7, 145-173.
4. Kay AB. - Allergy and allergic diseases. First of two parts. N Engl J Med, 2001, 344, 30-37.
5. Bach JF. - The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med, 2002, 347, 911-920.
6. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. - The inverse association between tuberculin responses and atopic disorder. Science, 1997, 275, 77-79.
7. Von Mutius E, Pearce N, Beasley R, et al. - International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax, 2000, 55, 449-453.
8. von Hertzen L, Klaukka T, Mattila H, Haahtela T. - Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol, 1999, 104, 1211-1214.
9. Aaby P, Shaheen SO, Heyes CB, et al. - Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy, 2000, 30, 644-650.
10. Marks GB, Ng K, Zhou J, et al. - The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: An historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol, 2003, 111, 541-549.
11. Omenaas E, Jentoft HF, Vollmer WM, et al. - Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax, 2000, 55, 454-458.
12. Herz U, Gerhold K, Gruber C, et al. - BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol, 1998, 102, 867-874.
13. Kline JN, Krieg AM, Waldschmidt TJ, et al. - CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol, 1999, 104, 1258-1264.
14. Tulic MK, Wale JL, Holt PG, Sly PD. - Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol, 2000, 22, 604-612.
15. Hattori H, Okano M, Yamamoto T, et al. - Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice. Clin Exp Allergy, 2002, 32, 951-959.
16. Zuany-Amorim C, Sawicka E, Manlius C, et al. - Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med, 2002, 8, 625-629.
17. Shirtcliffe PM, Easthope SE, Cheng S, et al. - The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med, 2001, 163, 1410-1414.
18. Camporota L, Corkhill A, Long H, et al. - The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J, 2003, 21, 287-293.
19. Arkwright PD, David TJ. - Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol, 2001, 107, 531-534.